Literature DB >> 30833220

Progress needed in bronchopulmonary dysplasia.

Ammara Mushtaq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30833220     DOI： 10.1016/S2213-2600(19)30075-X

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Recent research on the mechanism of mesenchymal stem cells in the treatment of bronchopulmonary dysplasia.

Authors:  Ke-Jin Xie; Ming-Yue Dong; Jing-Xuan Bai
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

2.  Deficiency of Integrin β4 Results in Increased Lung Tissue Stiffness and Responds to Substrate Stiffness via Modulating RhoA Activity.

Authors:  Yinxiu Chi; Yu Chen; Wang Jiang; Wenjie Huang; Mingxing Ouyang; Lei Liu; Yan Pan; Jingjing Li; Xiangping Qu; Huijun Liu; Chi Liu; Linhong Deng; Xiaoqun Qin; Yang Xiang
Journal:  Front Cell Dev Biol       Date:  2022-03-03

3.  Decorin Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Induces Macrophage Polarization via CD44 to Repair Hyperoxic Lung Injury.

Authors:  Ji Hye Kwon; Miyeon Kim; Yun Kyung Bae; Gee-Hye Kim; Soo Jin Choi; Wonil Oh; Soyoun Um; Hye Jin Jin
Journal:  Int J Mol Sci       Date:  2019-09-27       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.